Olopatadine use while Breastfeeding
Drugs containing Olopatadine: Patanol, Pataday, Patanase, Pazeo
Olopatadine Levels and Effects while Breastfeeding
Summary of Use during Lactation
Because absorption from the eye is limited, olopatadine would not be expected to cause any adverse effects in breastfed infants. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
References
Olopatadine Identification
Substance Name
Olopatadine
CAS Registry Number
113806-05-6
Drug Class
Anti-Allergic Agents
Antihistamines
Administrative Information
LactMed Record Number
627
Last Revision Date
20130907
Disclaimer
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.
